The Longevity Shift: strategic implications of the longevity medicine revolution
The Longevity Shift: strategic implications of the longevity medicine revolution

The Longevity Shift: Strategic implications of the longevity medicine revolution

Turn longevity from trend to strategy: where should pharma play - and how to win?

Longevity is emerging as one of the most dynamic frontiers in healthcare innovation. In 2025, longevity’s not just about living longer; it’s about preserving vitality, function and independence - creating new strategic options for portfolios and go to market.

Explore the strategic implications of the longevity market revolution:

  • Navigate five strategic categories, including GLP-1s
  • Map assets to longevity-relevant opportunities
  • Plan for regional regulatory pathways and access implications
  • Distinguish consumer activation models by market 

This new point of view maps the emergence of longevity medicine, the strategic implications and the growing recognition that longevity may become a defining theme in the future of medicine.
 

The author(s)

Related news

  • ASCO 2026

    ASCO 2026

    Join Ipsos at the world's largest oncology conference where we’ll be attending - and presenting Global Oncology Monitor insights!
  • [WEBINAR] 2026 KEYS: Dialing Up the 'S' in Sustainability
    Consumers Webinar

    [WEBINAR] 2026 KEYS: Dialing Up the 'S' in Sustainability

    Join Ipsos for its complimentary KEYS webinar series dedicated to helping brands and organizations better understand the dynamics of today as they prepare for tomorrow.
  • [WEBINAR] What the Future: Attention
    Media Events replay

    [WEBINAR] What the Future: Attention

    Hear about the emerging pushback against constant connectivity in favor of mindfulness and why building genuine brand communities might just be the antidote.